- Pancreas Cancer Academy 2022
- Breast Cancer Webinar
- NSCLC 2022 Webinar
- CECOG Immuno-Oncology Symposium
- Pancreatic Cancer
- Colon Cancer
- Post ESMO Webinar
- Post SABCS Webinar
- Videos
- Events
Playback speed
10 seconds
Expert Discussion on Resectable/Borderline-Resectable PAC: Gemcitabine in Neoadjuvant Setting, Paclitaxel-Gemcitabine, Adjuvant QT + RT in R1 Resected Tumors
0 views
March 31, 2021
Comments 0
Login to view comments.
Click here to Login
Pancreatic Cancer